US SB4191 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on July 2 2020 - 25% progression, died in committee
Action: 2020-07-02 - Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Pending: Senate Banking, Housing, And Urban Affairs Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 2 2020 - 25% progression, died in committee
Action: 2020-07-02 - Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Pending: Senate Banking, Housing, And Urban Affairs Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require a report on foreign investment in the pharmaceutical industry of the United States.
Title
United States Pharmaceutical Supply Chain Review Act
Sponsors
Sen. Elizabeth Warren [D-MA] | Sen. Marco Rubio [R-FL] |
History
Date | Chamber | Action |
---|---|---|
2020-07-02 | Senate | Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. |
Same As/Similar To
SB4175 (Related) 2020-07-02 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Congressional oversight
Genetics
Government information and archives
Government studies and investigations
Health
Health technology, devices, supplies
Industrial policy and productivity
Manufacturing
Prescription drugs
Retail and wholesale trades
U.S. and foreign investments
Genetics
Government information and archives
Government studies and investigations
Health
Health technology, devices, supplies
Industrial policy and productivity
Manufacturing
Prescription drugs
Retail and wholesale trades
U.S. and foreign investments
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/4191/all-info |
Text | https://www.congress.gov/116/bills/s4191/BILLS-116s4191is.pdf |